Literature DB >> 24666114

Headache care in China.

Shengyuan Yu1, Mingjie Zhang, Jiying Zhou, Ruozhuo Liu, Qi Wan, Yansheng Li.   

Abstract

Headache disorders are problematic worldwide. China is no different. A population-based door-to-door survey revealed that the 1-year prevalence of primary headache disorders in China was 23.8%, constituting a major societal burden. Many headache centers and clinics have been established in China, and headache disorders (and associated stress) are receiving an increased level of expert attention. This review summarizes the outcomes of the epidemiological survey and the progress of clinical and basic research in China, describes the present situation in terms of headache diagnosis and treatment, and discusses the future of headache care in China.
© 2014 American Headache Society.

Entities:  

Keywords:  China; care; epidemiology; headache; migraine; tension-type headache

Mesh：

Year:  2014        PMID： 24666114     DOI： 10.1111/head.12330

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


  10 in total

1.  Acupuncture treatment modulates the resting-state functional connectivity of brain regions in migraine patients without aura.

Authors:  Yong Zhang; Kuang-shi Li; Hong-wei Liu; Cai-hong Fu; Sheng Chen; Zhong-jian Tan; Yi Ren
Journal:  Chin J Integr Med       Date:  2015-04-06       Impact factor: 1.978

2.  New evidence for involvement of ESR1 gene in susceptibility to Chinese migraine.

Authors:  Xingkai An; Jie Fang; Qing Lin; Congxia Lu; Qilin Ma; Hongli Qu
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

3.  Migraine among students of a medical college in western China: a cross-sectional study.

Authors:  Haodi Yang; Shengxiong Pu; Yang Lu; Wenxiu Luo; Jiayu Zhao; Enzhuo Liu; Jiaming Yang; Xinya Luo; Xinyi Tang; Cheng Zeng; Jie Chen; Jiaming Luo
Journal:  Eur J Med Res       Date:  2022-05-23       Impact factor: 4.981

4.  A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Duliang Soft Capsule in Patients with Chronic Daily Headache.

Authors:  Shengyuan Yu; Yueqing Hu; Qi Wan; Jiying Zhou; Xinfeng Liu; Xiangyang Qiao; Xiaosu Yang; Jiachun Feng; Kangning Chen; Xiaoping Pan; Qingwu Yang; Linsen Dou; Ming Liu; Yangmei Chen; Tingmin Yu; Juming Yu; Zhiwei Li; Xue Bai; Jingfeng Duan
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-26       Impact factor: 2.629

Review 5.  Closing the treatment gap for mental, neurological and substance use disorders by strengthening existing health care platforms: strategies for delivery and integration of evidence-based interventions.

Authors:  Rahul Shidhaye; Crick Lund; Dan Chisholm
Journal:  Int J Ment Health Syst       Date:  2015-12-30

6.  Lifting the burden of headache in China: managing migraine in a SMART way.

Authors:  Shengyuan Yu; Timothy J Steiner
Journal:  J Headache Pain       Date:  2017-08-08       Impact factor: 7.277

7.  Common variants in KCNK5 and FHL5 genes contributed to the susceptibility of migraine without aura in Han Chinese population.

Authors:  Zhao Jiang; Longrui Zhao; Xiaojie Zhang; Wenjuan Zhang; Yuxing Feng; Tao Li
Journal:  Sci Rep       Date:  2021-03-24       Impact factor: 4.379

8.  Migraine attacks among medical students in Soochow University, Southeast China: a cross-sectional study.

Authors:  Xiao Gu; Yaojie Xie
Journal:  J Pain Res       Date:  2018-04-12       Impact factor: 3.133

9.  Studies on the Mechanism of Glutamate Metabolism in NTG-Induced Migraine Rats Treated with DCXF.

Authors:  Ni Ni; Qingqing Wang; Xiao Lin; Yanlong Hong; Yi Feng; Lan Shen
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-31       Impact factor: 2.629

10.  Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description

Authors:  Timothy J Steiner; Rigmor Jensen; Zaza Katsarava; Lars Jacob Stovner; Derya Uluduz; Latifa Adarmouch; Mohammed Al Jumah; Ali M Al Khathaami; Messoud Ashina; Mark Braschinsky; Susan Broner; Jon H Eliasson; Raquel Gil-Gouveia; Juan B Gómez-Galván; Larus S Gudmundsson; Akbar A Herekar; Nfwama Kawatu; Najib Kissani; Girish Baburao Kulkarni; Elena R Lebedeva; Matilde Leonardi; Mattias Linde; Otgonbayar Luvsannorov; Youssoufa Maiga; Ivan Milanov; Dimos D Mitsikostas; Teymur Musayev; Jes Olesen; Vera Osipova; Koen Paemeleire; Mario F P Peres; Guiovanna Quispe; Girish N Rao; Ajay Risal; Elena Ruiz de la Torre; Deanna Saylor; Mansoureh Togha; Sheng-Yuan Yu; Mehila Zebenigus; Yared Zenebe Zewde; Jasna Zidverc-Trajković; Michela Tinelli
Journal:  J Headache Pain       Date:  2021-07-21       Impact factor: 7.277
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.